ARTICLE | Product Development
COVID-19 update: Gilead ramping up remdesivir production; Codagenix partners with vaccine giant
February 13, 2020 10:52 PM UTC
Updated on Mar 26, 2020 at 1:35 AM UTC
Gilead is ramping up manufacturing of remdesivir, which is being tested as a potential treatment for COVID-19, the company told BioCentury Thursday. Gilead said it has not been in contact with BrightGene, a Chinese company that says it is manufacturing the investigational drug.
On Wednesday, BrightGene Bio-medical technology Co. Ltd. (Shanghai:688166) announced that it has synthesized the API and is mass producing remdesivir. BrightGene said it would seek authorization from Gilead Sciences Inc. (NASDAQ:GILD) to market the drug if remdesivir is approved in China...